Cornerstone National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Cornerstone National Bank & Trust's BMY Position: Q2 2026 in Review
Cornerstone National Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,000 shares worth $56.4K. The position accounts for 0.02% of the portfolio, ranked #120.
Cornerstone National Bank & Trust first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $524K in Q4 2019. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cornerstone National Bank & Trust held 1,000 shares of Bristol-Myers Squibb worth $56.4K as of Q2 2026.
- Cornerstone National Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #120 holding.
- Cornerstone National Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
- Cornerstone National Bank & Trust's Bristol-Myers Squibb position peaked at $524K in Q4 2019.
- 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.